Mountain View Clinical Research

Running trials

• Recruiting

  Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

  NCT07226661· Phase 2· Source

• Recruiting

  ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

  NCT07284667· Phase 2· Source

• Enrolling by invitation

  Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

  NCT06605105· Phase 3· Source

• Recruiting

  Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  NCT06547489· Phase 2· Source

• Recruiting

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Phase 3· Source

• Active, not recruiting

  Psilocybin for Major Depressive Disorder (MDD)

  NCT06308653· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

  NCT04586010· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression5 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

  NCT06785012· Phase 2· Source

• Completed

  "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

  NCT06564818· Phase 3· Source

• Completed

  Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis

  NCT03232073· Phase 3· Source